| A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain | Rebecca F. Grais, Primitive Gakima, Paul Baoundoh, Mbaihol Tamadji, Martha H. Roper, Florence Fermon, Céline Langendorf, Camille Domicent, Aitana Juan-Giner, Simona Zipursky | 2014 | Journal article | English |
| A field based evaluation of adverse events following MenAfriVac® vaccine delivered in a controlled temperature chain (CTC) approach in Benin | Christoph Steffen, Evariste Tokplonou, Philippe Jaillard, Roger Dia, Marie N Deye Bassabi Alladji, Bradford Gessner | 2014 | Journal article | English |
| An economic evaluation of the controlled temperature chain approach for vaccine logistics: evidence from a study conducted during a meningitis A vaccine campaign in Togo | Mvundura et all | 2017 | Journal article | English |
| Antivenoms, hepatitis B vaccine and oral polio vaccine can be considered for storage and handling outside the cold chain following the innovative 'controlled temperature chain' approach | Shereen H. Mohamed, Osama A. Hady, Mona T. Kashef, Hamdallah Zedan | 2022 | Journal article | English |
| Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin | Simona Zipursky, Mamoudou Harouna Djingarey, Jean-Claude Lodjo, Laifoya Olodo, Sylvestre Tiendrebeogo, Olivier Ronveaux | 2014 | Journal article | English |
| Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries | Debra D. Kristensen, Kate Bartholomew, Shirley Villadiego, Tina Lorenson | | Journal article | English |
| Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study | Nick Scott, Anna Palmer, Christopher Morgan, Olufunmilayo Lesi, Wendy Spearman, Mark Sonderup, Margaret Hellard | 2018 | Journal article | English |
| Countries’ interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions | Dörte Petit, Carole Tevi-Benissan, Joseph Woodring, Karen Hennessey, Anna-Lea Kahn | 2017 | Journal article | English |
| Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of Meningitis A vaccine in Chad | Patrick Lydon et al. | 2014 | Journal article | English |
| Evidence of Extended Thermo-Stability of Typhoid Polysaccharide Conjugate Vaccines | Fang Gao, Alastair Logan, Sarah Davis, Barbara Bolgiano, Sjoerd Rijpkema, Gopal Singh, Sai D. Prasad, Samuel Pradeep Dondapati, Gurbaksh Singh Sounkhla | 2021 | Journal article | English |
| Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines | Raja Rao, Debra Kristensen, Anna-Lea Kahn | 2017 | Journal article | English |
| Impact of Controlled Temperature Chain (CTC) approach on immunization coverage achieved during the preventive vaccination campaign against meningitis A using MenAfriVac in Togo in 2014 | Dadja Essoya Landoh, Anna-Lea Kahn, Anani Lacle, Kodjovi Adjeoda, Bayaki Saka, Issifou Yaya, Danladi Ibrahim Nassoury, Assima Kalao, Makawa-Sy Makawa, Nsiari-Mueyi Joseph Biey, Andre Bita, Yaovi Temfa Toke, Petit Dörte, Lucile Imboua, Olivier Ronveaux | 2017 | Journal article | English |
| Use of controlled temperature chain and compact prefilled auto-disable devices to reach 2030 hepatitis B birth dose vaccination targets in LMICs: a modelling and cost-optimisation study | Christopher P. Seaman, Christopher Morgan, Jess Howell, Yinzong Xiao, Wendy Spearman, Mark Sonderup | 2020 | Journal article | English |
